These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31371084)

  • 1. The hypertension advantage and natural selection: Since type 2 diabetes associates with co-morbidities and premature death, why have the genetic variants remained in the human genome?
    Lewis MT; Lujan HL; Wiseman RW; DiCarlo SE
    Med Hypotheses; 2019 Aug; 129():109237. PubMed ID: 31371084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.
    Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW
    Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of brainstem thyrotropin-releasing hormone-triggered sympathetic overactivation in cardiovascular mortality in type 2 diabetic Goto-Kakizaki rats.
    Yang H; Nyby MD; Ao Y; Chen A; Adelson DW; Smutko V; Wijesuriya J; Go VL; Tuck ML
    Hypertens Res; 2012 Feb; 35(2):157-65. PubMed ID: 21900943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP and aldosterone levels.
    Tanaka M; Sekioka R; Nishimura T; Ichihara A; Itoh H
    Diabetes Res Clin Pract; 2014 Dec; 106(3):504-10. PubMed ID: 25458339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic nervous system, diabetes, and hypertension.
    Perin PC; Maule S; Quadri R
    Clin Exp Hypertens; 2001; 23(1-2):45-55. PubMed ID: 11270588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and inactivity, not hyperglycemia, cause exercise intolerance in individuals with type 2 diabetes: Solving the obesity and inactivity versus hyperglycemia causality dilemma.
    Lewis MT; Lujan HL; Tonson A; Wiseman RW; DiCarlo SE
    Med Hypotheses; 2019 Feb; 123():110-114. PubMed ID: 30696579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats.
    Cheng ZJ; Vaskonen T; Tikkanen I; Nurminen K; Ruskoaho H; Vapaatalo H; Muller D; Park JK; Luft FC; Mervaala EM
    Hypertension; 2001 Feb; 37(2 Pt 2):433-9. PubMed ID: 11230314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats.
    Huang BS; Leenen FH
    Hypertension; 1999 Jul; 34(1):107-12. PubMed ID: 10406832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension in obesity and NIDDM. Role of insulin and sympathetic nervous system.
    Daly PA; Landsberg L
    Diabetes Care; 1991 Mar; 14(3):240-8. PubMed ID: 2044439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NaCl-induced hypertensive rat model of non-insulin-dependent diabetes: role of sympathetic modulation.
    Mozaffari MS; Patel C; Warren BK; Schaffer SW
    Am J Hypertens; 2000 May; 13(5 Pt 1):540-6. PubMed ID: 10826407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats.
    Carlson SH; Shelton J; White CR; Wyss JM
    Hypertension; 2000 Jan; 35(1 Pt 2):403-8. PubMed ID: 10642332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin and blood pressure regulation.
    Gans RO; Donker AJ
    J Intern Med Suppl; 1991; 735():49-64. PubMed ID: 2043223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of tne ACE insertion/deletion polymorphism with type 2 diabetes.
    Thomas GN; Tomlinson B; Chan JC; Sanderson JE; Cockram CS; Critchley JA
    Diabetes Care; 2001 Feb; 24(2):356-61. PubMed ID: 11213892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopeptidase inhibition has beneficial cardiac effects in spontaneously diabetic Goto-Kakizaki rats.
    Grönholm T; Cheng ZJ; Palojoki E; Eriksson A; Bäcklund T; Vuolteenaho O; Finckenberg P; Laine M; Mervaala E; Tikkanen I
    Eur J Pharmacol; 2005 Sep; 519(3):267-76. PubMed ID: 16137672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinemia, insulin resistance, and hypertension.
    Bönner G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
    Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
    Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin resistance and arterial hypertension].
    Weidmann P; Müller-Wieland D; de Courten M; Krone W
    Herz; 1995 Feb; 20(1):16-32. PubMed ID: 7713473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular and renal effects of vasopeptidase inhibition and angiotensin-converting enzyme blockade in spontaneously diabetic Goto-Kakizaki rats.
    Cheng ZJ; Grönholm T; Louhelainen M; Finckenberg P; Merasto S; Tikkanen I; Mervaala E
    J Hypertens; 2005 Sep; 23(9):1757-70. PubMed ID: 16093923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.